Literature DB >> 21605973

Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties.

Thorsten Oost1, Gisela Backfisch, Swati Bhowmik, Marcel M van Gaalen, Hervé Geneste, Wilfried Hornberger, Wilfried Lubisch, Astrid Netz, Liliane Unger, Wolfgang Wernet.   

Abstract

Herein we report the discovery of a novel series of vasopressin 1b (V1b) receptor antagonists, starting from potent but metabolically labile oxindole SSR149415. Masking the proline N,N-dimethyl amide moiety as an oxazole and attaching a benzylic amine moiety to the northern phenyl ring resulted in potent and selective V1b receptor antagonists with improved metabolic stability and improved pharmacokinetic properties in rat. Compound 18c was found to be efficacious in a rat model of anti-depressant activity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605973     DOI: 10.1016/j.bmcl.2011.03.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  The vasopressin 1b receptor and the neural regulation of social behavior.

Authors:  Erica L Stevenson; Heather K Caldwell
Journal:  Horm Behav       Date:  2011-12-07       Impact factor: 3.587

2.  V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice.

Authors:  Yan Zhou; Marcelo Rubinstein; Malcolm J Low; Mary Jeanne Kreek
Journal:  Alcohol Clin Exp Res       Date:  2017-11-28       Impact factor: 3.455

Review 3.  Social Context, Stress, Neuropsychiatric Disorders, and the Vasopressin 1b Receptor.

Authors:  Heather K Caldwell; Elizabeth A Aulino; Karla M Rodriguez; Shannah K Witchey; Alexandra M Yaw
Journal:  Front Neurosci       Date:  2017-10-16       Impact factor: 4.677

4.  One step access to oxindole-based β-lactams through Ugi four-center three-component reaction.

Authors:  Giulia Rainoldi; Giordano Lesma; Claudia Picozzi; Leonardo Lo Presti; Alessandra Silvani
Journal:  RSC Adv       Date:  2018-10-11       Impact factor: 4.036

Review 5.  Vasopressin V1B Receptor Antagonists as Potential Antidepressants.

Authors:  Shigeyuki Chaki
Journal:  Int J Neuropsychopharmacol       Date:  2021-07-14       Impact factor: 5.176

6.  Guanidine-Amide-Catalyzed Aza-Henry Reaction of Isatin-Derived Ketimines: Origin of Selectivity and New Catalyst Design.

Authors:  Jiajia He; Dianyong Tang; Changwei Hu; Zhishan Su
Journal:  Molecules       Date:  2021-03-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.